Biography
Tung-Jui Trieu received his BSc in Life Sciences, and his Master’s degree in Cell Biology from Pierre & Marie Curie University - Paris VI, France. At the Institut Pasteur in Paris, he completed an internship in the laboratory of Experimental neurobiology under the supervision of Prof. Fabrice Chrétien.
His studies focused on the impact of sepsis on skeletal muscle and on the niche of satellite cells. He also investigated the regeneration capacities of skeletal muscle during sepsis. After completion of his Master, Tung-Jui moved to the UK and joined King’s College London where he completed his PhD in Dr. Shukry Habib laboratory, in the Centre for Stem Cells & Regenerative Medicine at Guy’s Hospital.
His graduate studies focused on the mechanisms of Wnt-mediated asymmetric stem cell division and the subcellular localisation of Adenomatous Polyposis Coli (APC).
Currently, Tung-Jui is a research associate in Dr Joana F Neves group, in the Centre for Host-Microbiome Interactions at Guy’s Hospital, and will take a central role on the setting up and the development of an intestinal organoid platform, Gut-HOP, funded by King’s Together Strategic Award.
Research
Neves Lab
The Neves lab aims understand how the different cellular compartments of the gut communicate with each other, to then be able to direct those conversations to promote gut homeostasis.
IBD and Complex Genetics Group
The IBD and Complex Genetics Group is led by Dr Natalie Prescott that conducts research on inflammatory bowel disease.
News
Gut and lung organoids open the door to innate immune cell therapies
King’s researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.
Research
Neves Lab
The Neves lab aims understand how the different cellular compartments of the gut communicate with each other, to then be able to direct those conversations to promote gut homeostasis.
IBD and Complex Genetics Group
The IBD and Complex Genetics Group is led by Dr Natalie Prescott that conducts research on inflammatory bowel disease.
News
Gut and lung organoids open the door to innate immune cell therapies
King’s researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.